研究成果
年分
作者
期刊
研究名稱
2019
Chang TY, Lip GYH, Chen SA, Chao TF*.
Can. J. Cardiol. 2019; 35(5) 611-618. (IF: 5.592) 342-344 (IF: 1.676)
Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process.
2019
Vasquez N, Ostrander BT, Lu DY, Ventoulis I, Haileselassie B, Goyal S, Greenland GV, Vakrou S, Olgin JE, Abraham TP, Abraham MR*.
J. Am. Soc. Echocardiogr. 2019; 32(5) 593-+ (IF: 6.111)
Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.
2019
Wei JH*, Lee WJ, Lin SJ, Huang PH.
Surg. Obes. Relat. Dis. 2019; 15(2) 353-354. (IF: 3.758)
Reply letter to the editor metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: influence of different surgical procedures.
2019
Chao TF*, Chiang CE, Chen TJ, Lip GYH, Chen SA.
Ann. Intern. Med. 2019; 170(9) 663-+ (IF: 19.315)
Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation.
2019
Chang HC, Cheng HM*.
J. Clin. Hypertens. 2019; 21(5) 616-617. (IF: 2.444)
P wave peak time: A time window to evaluate left ventricular diastolic function.
2019
Song HY, Chien CS, Yarmishyn AA, Chou SJ, Yang YP, Wang ML, Wang CY, Leu HB, Yu WC, Chang YL, Chiou SH.
Cells. 2019;8(4):327.
Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy.
2019
Lin YJ*, Lin CY, Chen SA.
Curr. Opin. Cardiol. 2019; 34(1) 16-22. (IF: 1.979)
Ablation of persistent atrial fibrillation and beyond.
2019
Chen CY, Hsu SC, Hsieh HL, Suk CW, Hsu YP, Sue YM, Chen OH, Lin FE, Shih CM, Chen AW, Lin SO, Huang PS, Liu CT*.
PLoS One. 2019; 14(5)- (IF: 2.776)
Microbial etiology of pneumonia in patients with decreased renal function.
2019
Cheng HM, Sung SH, Chen CH, Yu WC, Yang SM, Guo CY, Chuang SY, Chiang CE*.
Trials. 2019;20(1):265.
Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies (GYMNs study): comparison of three different blood pressure measurement methods: study protocol for a randomized controlled trial.
2019
Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ*, Florkowski CM, George PM, Lin J, Loi DD, Marais AD, Nawawi HM, Gonzalez-Santos LE, Su TC, Truong TH, Santos RD, Soran H, Tomlinson B, Yamashita S, Ademi Z, Watts GF.
J. Clin. Lipidol. 2019; 13(2) 287-300. (IF: 3.581)
48.
49. Trials. 2019; 20() (IF:)
50. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".